新莱应材(300260) - 2021 Q4 - 年度财报

Financial Performance - The company reported a total revenue of 226,559,307 RMB for the year 2021, with a cash dividend of 0.80 RMB per 10 shares distributed to all shareholders[6]. - The company's operating revenue for 2021 was CNY 2,054,412,270.36, representing a 55.28% increase from CNY 1,323,047,161.12 in 2020[30]. - The net profit attributable to shareholders in 2021 was CNY 169,811,133.29, a 105.66% increase compared to CNY 82,568,134.76 in 2020[30]. - The net profit after deducting non-recurring gains and losses was CNY 161,511,796.39, up 128.76% from CNY 70,603,438.72 in 2020[30]. - The company's cash flow from operating activities was CNY 174,358,788.37, an increase of 59.85% from CNY 109,073,660.29 in 2020[30]. - The total assets at the end of 2021 were CNY 2,939,904,160.73, a 26.18% increase from CNY 2,329,920,512.69 at the end of 2020[30]. - The net assets attributable to shareholders at the end of 2021 were CNY 1,267,833,403.58, reflecting a 14.25% increase from CNY 1,109,683,437.42 at the end of 2020[30]. - The company achieved a basic earnings per share of CNY 0.75 in 2021, up 82.93% from CNY 0.41 in 2020[30]. - The company reported a quarterly revenue of CNY 576,123,113.98 in Q4 2021, contributing to a total annual revenue growth[31]. - The company received government subsidies amounting to CNY 9,866,998.57 in 2021, which are closely related to its normal business operations[36]. Market Expansion and Strategy - The company plans to expand its market presence and enhance its product offerings in the semiconductor and biopharmaceutical sectors, focusing on process contamination control technologies[19]. - The company aims to leverage its expertise in clean application materials to capture opportunities in emerging markets[19]. - The company operates in high-growth sectors such as semiconductor, optoelectronics, and biomedicine, which are expected to benefit from government support during the 14th Five-Year Plan[42]. - The company is actively pursuing market expansion and product development through strategic partnerships and collaborations with key industry players[108]. - The company has established partnerships with various entities to enhance its technological capabilities and market reach[19]. Research and Development - The company is investing in research and development for new electronic film materials aimed at the semiconductor and photovoltaic industries[19]. - The company has a strong focus on R&D, continuously improving its products to meet the evolving needs of the semiconductor and biomedicine industries[79]. - The company has established a robust R&D management system, focusing on key process improvements and new product development, supported by a team with over 20 years of industry experience[94]. - The R&D investment in 2021 amounted to CNY 74.32 million, representing 3.62% of operating revenue, a decrease from 4.90% in 2020[142]. - The R&D personnel count increased by 1.08% to 188 in 2021, while the proportion of R&D staff to total employees decreased to 7.71%[142]. Product Development and Innovation - The company is developing semiconductor vacuum chamber technology to improve vacuum degree, cleanliness, and dimensional accuracy while reducing energy consumption[130]. - The R&D of semiconductor specialty gas system electro-polishing technology aims to meet high purity process requirements, enhancing overall technology levels in the semiconductor industry[133]. - The company is currently developing a new 330ml smile pack with innovative design features aimed at enhancing consumer experience and targeting high-end dairy product markets[136]. - The company is focusing on biodegradable plastic applications in sterile packaging, aligning with environmental trends and increasing market demand[139]. - The company is actively working on easy-open preformed hole packaging technology to improve product safety and quality, particularly for liquid food applications[139]. Quality Control and Compliance - The company emphasizes the importance of maintaining accurate financial reporting and has ensured compliance with legal responsibilities regarding the annual report[5]. - The financial report has been audited by a reputable accounting firm, ensuring the integrity of the financial data presented[12]. - The company has implemented strict quality management practices, ensuring high standards from raw material procurement to final product inspection[99]. - The company has received multiple international certifications, including ISO9001 and ASME, ensuring compliance with global quality standards[104]. Operational Efficiency - The company has maintained a strong focus on cost control and operational efficiency, leading to steady profit growth during the reporting period[98]. - The company's production model is based on "sales-driven production" and "sales forecast-driven production," ensuring efficient capacity allocation and timely order fulfillment[91]. - The company has established a stable procurement model, ensuring quality supply of raw materials, particularly stainless steel, through long-term partnerships with suppliers[87]. Industry Trends and Insights - In 2021, China's integrated circuit industry sales reached CNY 1,045.83 billion, a year-on-year increase of 18.2%[44]. - The semiconductor manufacturing sales in China amounted to CNY 317.63 billion, growing by 24.1% year-on-year[44]. - Global semiconductor revenue totaled USD 595 billion in 2021, reflecting a growth of 26.3% compared to 2020[45]. - The pharmaceutical manufacturing industry in China achieved a revenue of CNY 2,928.85 billion in 2021, up 17.83% year-on-year[58]. - The global vaccine market size is projected to grow from USD 64 billion in 2021 to USD 112.7 billion by 2030, excluding COVID-19 vaccines, highlighting the expanding market potential[67]. Financial Management and Investments - The company has effectively controlled expenditures, resulting in lower equipment investment compared to budget[181]. - The company plans to use 8,200 million yuan from the raised funds to expand the high-purity and ultra-high-purity stainless steel pipe production project to meet increasing market demand[167]. - The company is adopting a prudent investment strategy to mitigate economic pressures and ensure the rational use of raised funds[167]. - The total amount of raised funds allocated to various projects reached 67,028.31 million yuan, with 66,191.15 million yuan effectively utilized[165]. - The company has not reported any issues regarding the use and disclosure of raised funds for the year[184].